StemCell Therapy

Dublin, March 10, 2020 (GLOBE NEWSWIRE) -- The "Biomarkers Market Size, Share & Trends Analysis Report by Type (Safety, Efficacy, Validation), by Application (Diagnostic, Drug Development, Personalized Medicine), by Disease, and Segment Forecasts, 2020-2027" report has been added to ResearchAndMarkets.com's offering.

The global biomarkers market size is expected to reach over USD 129.4 billion by 2027. It is anticipated to exhibiting a CAGR of 13.7%, during the forecast period. Factors, such as increasing collaborations and funds for R&D activities, rising consumer awareness, a widening patient base, and technological advancements collectively augmenting market growth.

The drug discovery segment contributed the highest revenue in 2019. Pharmaceutical companies focus on extensive R&D initiatives for the development of targeted therapeutics. Coordinated strategic efforts on biomarker development remain a searing trend among drug manufacturers, academic research institutions, commercial R&D organizations, non-profitable health foundations, and federal government biomedical regulatory and research agencies.

North America continued to lead the biomarkers market in 2019, driven by an amplifying demand for personalized medicines, high disease prevalence, and proactive government initiatives. It is expected to maintain its lead over the forecast period. Asia Pacific is positioned to witness the fastest CAGR, over the forecast period, spearheaded by India.

Some key market players include Abbott, Roche, Qiagen, Siemens Healthcare, Thermo Fisher Scientific, Bio-Rad Laboratories, Johnson & Johnson Services, Agilent Technologies, and Epigenomics. The players are developing novel kits and therapies and drugs to target population in the areas with high unmet clinical needs.

Further key findings from the study suggest:

Key Topics Covered

Chapter 1 Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Biomarkers Market Variables, Trends & Scope3.1. Biomarkers Market Lineage Outlook3.1.1. Clinical Diagnostics Market Outlook3.2. Penetration & Growth Prospect Mapping3.3. Regulatory Framework3.3.1. Reimbursement Framework3.3.2. Standards & Compliances3.4. Market Dynamics3.4.1. Market Driver Analysis3.4.1.1. Increasing Prevalence of Chronic Diseases3.4.1.2. Technological Advancements3.4.1.3. Funding for Biomarkers3.4.2. Market Restraint Analysis3.4.2.1. Reimbursement Policies3.5. Biomarkers Market Analysis Tools3.5.1. Industry Analysis - Porter's3.5.2. PESTEL Analysis3.5.3. Major Deals & Strategic Alliances Analysis

Chapter 4. Biomarkers Market - Competitive Analysis4.1. Recent Developments & Impact Analysis, by Key Market Participants4.2. Company/Competition Categorization (Key Innovators, Market Leaders, Emerging Players)4.3. Vendor Landscape4.3.1. List of Key Distributors and Channel Partners4.3.2. Key Company Market Share Analysis, 20194.4. Public Companies4.4.1. Company Market Position Analysis (Revenue, Geographic Presence, Product Portfolio, Key Serviceable Industries, Key Alliances)4.4.2. Company Market Share4.4.3. Competitive Dashboard Analysis4.4.4. Market Differentiators4.4.5. Synergy Analysis: Major Deals & Strategic Alliances4.5. Private Companies4.5.1. List of Key Emerging Companies4.5.2. Regional Network Map4.5.3. Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)

Chapter 5. Biomarkers Market: Type Estimates & Trend Analysis5.1. Definitions & Scope5.2. Type Market Share Analysis, 2019 & 20275.3. Biomarkers Market, by Type, 2015 to 20275.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following:5.4.1. Safety5.4.2. Efficacy5.4.3. Validation

Chapter 6. Biomarkers Market: Application Estimates & Trend Analysis6.1. Definitions & Scope6.2. Application Market Share Analysis, 2019 & 20276.3. Biomarkers Market, by Application, 2015 to 20276.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following:6.4.1. Diagnostics6.4.2. Drug Development6.4.3. Personalized Medicine

Chapter 7. Biomarkers Market: Disease Estimates & Trend Analysis7.1. Definitions & Scope7.2. Disease Market Share Analysis, 2019 & 20277.3. Biomarkers Market, by Disease, 2015 to 20277.4. Market Size & Forecasts and Trend Analyses, 2015 to 2027 for the following:7.4.1. Cancer7.4.2. Cardiovascular Disease7.4.3. Neurological Disease7.4.4. Immunological Disease7.4.5. Others7.5. Disease Market, by Type, 2015-2027:7.5.1. Cancer7.5.2. Cardiovascular Diseases7.5.3. Neurological Disease7.5.4. Imunological Disease7.5.5. Others

Chapter 8 Biomarkers Market: Regional Estimates & Trend Analysis8.1 Biomarkers Market: Regional Movement Analysis, 2019 & 20278.2 Biomarkers Market: Leading Players, 20198.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)8.4 North America8.5 Europe8.6 Asia-Pacific8.7 Latin America8.8 MEA

Chapter 9 Competitive Landscape9.1 Strategy Framework9.2 Heat Map Analysis of Private Companies9.3 F-Hoffman La Roche Ltd.9.4 Abbott9.5 Epigenomics AG9.6 General Electric Company9.7 Johnson & Johnson9.8 Thermo Fisher Scientific Inc.9.9 Bio-Rad Laboratories Inc.9.10 Siemens Healthcare Private Limited9.11 Qiagen

For more information about this report visit https://www.researchandmarkets.com/r/1r1wle

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

More here:
Global Biomarkers Market Outlook, 2020-2027 - Featuring Profiles of Key Players Abbott, Roche, Qiagen, Siemens Healthcare, Thermo Fisher Scientific,...

This entry was posted on March 10, 2020 at 7:47 pm and is filed under Personalized Medicine. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed. |